The settlement resolves allegations that Aperian paid kickbacks to marketing companies in exchange for arranging for physicians across the nation to refer toxicology tests to the lab, according to The Times-News. EAMC and Aperian allegedly submitted claims for the toxicology lab tests to Medicare in violation of the False Claims Act.
A former Aperian employee brought the case under the qui tam, or whistle-blower, provisions of the False Claims Act.
The $4.25 million settlement is in addition to earlier settlements in the same case that totaled nearly $2.4 million, according to The Times-News.
More articles on legal and regulatory issues:
11 latest healthcare industry lawsuits
Partners, Massachusetts Eye and Ear settle deceptive billing allegations
Physician pleads guilty in $60M fraud scheme allegedly linked to patient deaths
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
